Schramm Vern Lee 4
4 · AzurRx BioPharma, Inc. · Filed Oct 1, 2018
Insider Transaction Report
Form 4
Schramm Vern Lee
Director
Transactions
- Award
Common Stock
2018-09-28$2.57/sh+7,500$19,275→ 30,000 total
Footnotes (1)
- [F1]Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2018.